Safety, Tolerability, PK and PD of ADX-850 in Participants With Hypertension
Safety, Tolerability, PK and PD of ADX-850 in Participants With Hypertension
Active, not recruiting · NCT06205628 · Registry updated 2026-09-03Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety, Tolerability, PK and PD of ADX-850 in Participants With Hypertension | cardiovascular disorder, essential hypertension, hypertensive disorder, vascular disorder | Active, not recruiting | Phase 1 | 2026-09-03 | NCT06205628 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| ADARx Australia Pty Ltd | 2 |
| ADARx Pharmaceuticals, Inc. | 9 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Clinitrials Pty Ltd | Perth | Australia | 1 |
| Cmax Clinical Research | Adelaide | Australia | 10 |
| Linear Clinical Research | Nedlands | Australia | 23 |